| A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which … V Ramasamy, U Arora, R Shukla, A Poddar, RK Shanmugam, LJ White, ... PLoS neglected tropical diseases 12 (1), e0006191, 2018 | 83 | 2018 |
| Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies S Mani, L Tripathi, R Raut, P Tyagi, U Arora, T Barman, R Sood, A Galav, ... PLoS one 8 (5), e64595, 2013 | 75 | 2013 |
| Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice U Arora, P Tyagi, S Swaminathan, N Khanna Vaccine 31 (6), 873-878, 2013 | 66 | 2013 |
| Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2 U Arora, P Tyagi, S Swaminathan, N Khanna Journal of nanobiotechnology 10, 1-6, 2012 | 64 | 2012 |
| Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies L Tripathi, S Mani, R Raut, A Poddar, P Tyagi, U Arora, A De Silva, ... Frontiers in microbiology 6, 1005, 2015 | 40 | 2015 |
| Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement … R Shukla, RK Rajpoot, U Arora, A Poddar, S Swaminathan, N Khanna Frontiers in microbiology 8, 2644, 2018 | 36 | 2018 |
| Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris N Kaushik, D Rohila, U Arora, R Raut, U Lamminmäki, N Khanna, G Batra BMC biotechnology 16, 1-9, 2016 | 34 | 2016 |
| Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed … A Poddar, V Ramasamy, R Shukla, RK Rajpoot, U Arora, SK Jain, ... BMC biotechnology 16, 1-10, 2016 | 29 | 2016 |
| Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising … RK Rajpoot, R Shukla, U Arora, S Swaminathan, N Khanna Scientific Reports 8 (1), 8643, 2018 | 28 | 2018 |
| Recombinant dengue virus 4 envelope glycoprotein virus-like particles derived from Pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies N Khetarpal, R Shukla, RK Rajpoot, A Poddar, M Pal, S Swaminathan, ... The American Journal of Tropical Medicine and Hygiene 96 (1), 126, 2017 | 27 | 2017 |
| Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation RK Shanmugam, V Ramasamy, R Shukla, U Arora, S Swaminathan, ... Pathogens and disease 77 (3), ftz026, 2019 | 24 | 2019 |
| Cocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity R Shukla, RK Rajpoot, A Poddar, R Ahuja, H Beesetti, RK Shanmugam, ... Frontiers in Microbiology 12, 746110, 2021 | 18 | 2021 |
| Dengue-specific subviral nanoparticles: design, creation and characterization N Khetarpal, A Poddar, SK Nemani, N Dhar, A Patil, P Negi, A Perween, ... Journal of nanobiotechnology 11, 1-8, 2013 | 18 | 2013 |
| Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement R Shukla, RK Shanmugam, V Ramasamy, U Arora, G Batra, JA Acklin, ... EBioMedicine 54, 2020 | 13 | 2020 |
| Next generation designer virus-like particle vaccines for dengue R Shukla, V Ramasamy, RK Rajpoot, U Arora, A Poddar, R Ahuja, ... Expert review of vaccines 18 (2), 105-117, 2019 | 11 | 2019 |
| Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity R Shukla, R Ahuja, H Beesetti, A Garg, C Aggarwal, S Chaturvedi, ... Scientific reports 13 (1), 1026, 2023 | 5 | 2023 |
| Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and … SK Dar, S Kumar, S Maiti, S Dhawan, S Joglekar, U Arora, R Kalra, ... Heliyon 8 (5), 2022 | 4 | 2022 |
| A multicentric study to ascertain knowledge, attitude and practices for infection prevention and control amongst nurses R Gupta, S Sharma, A Yadav, U Arora, S Bhattar, BL Sherwal Journal of Patient Safety and Infection Control 8 (1), 21-28, 2020 | 3 | 2020 |
| Use of cocculus hirsutus extract for treating dengue K Nayyar, U Arora, S Palla, M Prasad, A Saravanan, S Madan, R Sood, ... US Patent App. 17/311,161, 2022 | 2 | 2022 |
| Cocculus hirsutus-derived phytopharmaceutical drug has potent anti-dengue activity A Poddar, R Shukla, H Beesetti, U Arora, RK Rajpoot, RK Shanmugam, ... bioRxiv, 2020.09. 18.303149, 2020 | 2 | 2020 |
